Intra-Cellular Therapies Inc. buy melinda
Start price
30.08.17
/
50%
€16.35
Target price
27.12.17
€22.55
Performance (%)
-14.01%
End price
27.12.17
€14.06
Summary
This prediction ended on 27.12.17 with a price of €14.06. The price of Intra-Cellular Therapies Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.01%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Intra-Cellular Therapies Inc. | -4.965% | -4.965% | 10.744% | 82.661% |
iShares Core DAX® | 0.611% | -2.723% | 14.325% | 14.359% |
iShares Nasdaq 100 | -0.208% | 6.703% | 37.781% | 55.710% |
iShares Nikkei 225® | 1.298% | 1.009% | 9.641% | 4.825% |
iShares S&P 500 | 0.636% | 5.035% | 30.827% | 48.685% |
Comments by melinda for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Therapien
ITCI auf dem richtigen Weg für die Einreichung der NDA bis Mitte 2018
(Vom Mitglied beendet)
Stopped prediction by melinda for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€11.81
04.04.19
04.04.19
€18.04
04.11.21
04.11.21
233.36%
05.11.21
05.11.21
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€18.13
30.08.17
30.08.17
€25.00
27.12.17
27.12.17
-14.01%
27.12.17
27.12.17